Polar Capital’s Guardant Health GH Stock Holding History

Polar Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,951	Closed	-$345K	–	296
2020 Q1	$345K	Buy	+4,951	New	+$380K	﹤0.01%	279

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Polar Capital's GH Position: Q2 2020 in Review

Polar Capital sold out of Guardant Health (GH) in Q2 2020, closing a stake of 4,951 shares — an estimated $345K sold.

Polar Capital first reported a position in GH in Q1 2020 and held it in 1 quarter. The position peaked at $345K in Q1 2020. 325 funds tracked by Wall St. Rank hold GH as of Q2 2020.

Polar Capital reported no remaining Guardant Health position as of Q2 2020 after selling out during the quarter.
Polar Capital sold 4,951 Guardant Health shares in Q2 2020, an estimated $345K.
Polar Capital first reported a position in Guardant Health in Q1 2020 and held it in 1 quarter.
Polar Capital's Guardant Health position peaked at $345K in Q1 2020.
325 funds tracked by Wall St. Rank held Guardant Health as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.